PE20040071A1 - Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion - Google Patents
Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacionInfo
- Publication number
- PE20040071A1 PE20040071A1 PE2003000232A PE2003000232A PE20040071A1 PE 20040071 A1 PE20040071 A1 PE 20040071A1 PE 2003000232 A PE2003000232 A PE 2003000232A PE 2003000232 A PE2003000232 A PE 2003000232A PE 20040071 A1 PE20040071 A1 PE 20040071A1
- Authority
- PE
- Peru
- Prior art keywords
- indazol
- chloro
- compositions containing
- manufacturing procedure
- substituted indazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
SE REFIERE A INDAZOLES DE FORMULA I DONDE R1 ES H, HALO, ALQUILO, ALQUILENO, ALQUINILO, ARILO, HETEROARILO, CICLOALQUILO, HETEROCICLILO, ALQUILO SUSTITUIDO CON ALQUILENO, ENTRE OTROS; X ES S(O2)-NH, S(O2)-O, NH-S(O2), O-S(O2); Z ES ALQUILO, ARILO, HETEROARILO, CICLOALQUILO, HETEROCICLILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS N-(3-CLORO-1H-INDAZOL-5-IL)-2-METILSULFONILBENCENOSULFONAMIDA, N-(3-CLORO-1H-INDAZOL-5-IL)-3,4-DICLOROBENCENOSULFONAMIDA, N-(3-CLORO-1H-INDAZOL-5-IL)-3-FLUORBENCENOSULFONAMIDA, N-(3-CIANO-1H-INDAZOL-5-IL)-3-FLUORBENCENOSULFONAMIDA, 3,4-DICLORO-N-(3-FENIL-1H-INDAZOL-5-IL)-BENCENOSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS PRESENTAN ACTIVIDAD INHIBIDORA DE LAS CINASAS POR LO QUE SON UTILES COMO ANTICANCERIGENOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0202996A FR2836914B1 (fr) | 2002-03-11 | 2002-03-11 | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20040071A1 true PE20040071A1 (es) | 2004-02-13 |
Family
ID=27763684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2003000232A PE20040071A1 (es) | 2002-03-11 | 2003-03-07 | Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion |
Country Status (29)
Country | Link |
---|---|
US (2) | US6858638B2 (es) |
EP (1) | EP1487803A1 (es) |
JP (1) | JP4643910B2 (es) |
KR (1) | KR20040091128A (es) |
CN (1) | CN100369899C (es) |
AR (1) | AR038914A1 (es) |
AU (1) | AU2003242808B2 (es) |
BR (1) | BR0308339A (es) |
CA (1) | CA2478540A1 (es) |
EC (1) | ECSP045286A (es) |
FR (1) | FR2836914B1 (es) |
GT (1) | GT200300031A (es) |
HN (1) | HN2003000094A (es) |
HR (1) | HRP20040825A2 (es) |
IL (2) | IL163805A0 (es) |
MA (1) | MA27176A1 (es) |
MX (1) | MXPA04008446A (es) |
NO (1) | NO20044261L (es) |
OA (1) | OA12784A (es) |
PA (1) | PA8566701A1 (es) |
PE (1) | PE20040071A1 (es) |
PL (1) | PL372389A1 (es) |
RU (1) | RU2004130280A (es) |
SV (1) | SV2003001493A (es) |
TN (1) | TNSN04175A1 (es) |
TW (1) | TW200303863A (es) |
UY (1) | UY27712A1 (es) |
WO (1) | WO2003078402A1 (es) |
ZA (1) | ZA200406730B (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
GB0218625D0 (en) * | 2002-08-10 | 2002-09-18 | Astex Technology Ltd | Pharmaceutical compounds |
AU2003286711A1 (en) * | 2002-10-25 | 2004-05-13 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
WO2005014554A1 (en) * | 2003-08-08 | 2005-02-17 | Astex Therapeutics Limited | 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |
FR2864084B1 (fr) | 2003-12-17 | 2006-02-10 | Aventis Pharma Sa | Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments |
EP1694686A1 (en) * | 2003-12-19 | 2006-08-30 | Takeda San Diego, Inc. | Kinase inhibitors |
GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
GB0330042D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
US20050250829A1 (en) * | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Kinase inhibitors |
EP1778669A2 (en) * | 2004-08-18 | 2007-05-02 | Takeda San Diego, Inc. | Kinase inhibitors |
CA2581865C (en) * | 2004-09-29 | 2010-04-20 | F. Hoffmann-La Roche Ag | Indazolone derivatives as 11b-hsd1 inhibitors |
DE602005023333D1 (de) | 2004-10-15 | 2010-10-14 | Takeda Pharmaceutical | Kinaseinhibitoren |
SE0402762D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
CN101243051A (zh) * | 2005-08-25 | 2008-08-13 | 霍夫曼-拉罗奇有限公司 | p38 MAP激酶抑制剂及使用它的方法 |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
PL1981851T3 (pl) | 2006-01-31 | 2012-07-31 | Array Biopharma Inc | Inhibitory kinazy i sposoby ich stosowania |
US20100120717A1 (en) | 2006-10-09 | 2010-05-13 | Brown Jason W | Kinase inhibitors |
EP2223925A1 (en) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
WO2008063888A2 (en) * | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
FR2917735B1 (fr) * | 2007-06-21 | 2009-09-04 | Sanofi Aventis Sa | Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique |
JP5364875B2 (ja) * | 2007-07-16 | 2013-12-11 | アッヴィ・インコーポレイテッド | タンパク質キナーゼ阻害薬としてのインダゾール類、ベンゾイソオキサゾール類およびベンゾイソチアゾール類 |
US20220315555A1 (en) | 2009-05-26 | 2022-10-06 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
ES2546294T3 (es) * | 2009-05-26 | 2015-09-22 | Abbvie Bahamas Ltd. | Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias |
US9034875B2 (en) | 2009-05-26 | 2015-05-19 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
US8546399B2 (en) | 2009-05-26 | 2013-10-01 | Abbvie Inc. | Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
WO2011050245A1 (en) * | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
CN102247361B (zh) * | 2010-05-20 | 2015-04-29 | 中国医学科学院药物研究所 | 5-硝基-1氢-吲唑-3-腈在制备药物中的应用 |
BR112013009093B1 (pt) | 2010-10-29 | 2022-04-19 | Abbvie Inc | Processo para a preparação de uma dispersão sólida contendo um agente indutor de apoptose |
UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
RU2593231C2 (ru) | 2010-11-23 | 2016-08-10 | ЭббВи Айэленд Анлимитед Компани | Способы лечения с использованием селективных ингибиторов bcl-2 |
NO2643322T3 (es) | 2010-11-23 | 2018-01-27 | ||
US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
MX2017005719A (es) | 2014-11-03 | 2017-12-07 | Iomet Pharma Ltd | Compuesto farmaceutico. |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
EP3654972A4 (en) * | 2017-07-21 | 2021-03-17 | Kadmon Corporation, LLC | KINASE PROTEIN INHIBITORS CONTAINING A COIL COIL ASSOCIATED WITH RHO |
US11186549B2 (en) | 2017-08-29 | 2021-11-30 | Rutgers, The State University Of New Jersey | Therapeutic indazoles |
WO2023137041A1 (en) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
CN114605329B (zh) * | 2022-03-28 | 2024-01-26 | 河南中医药大学 | 取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS514505Y2 (es) | 1971-02-13 | 1976-02-07 | ||
JPH061350B2 (ja) * | 1985-07-26 | 1994-01-05 | コニカ株式会社 | ハロゲン化銀写真感光材料 |
EP0896533B1 (en) | 1996-02-22 | 2003-09-10 | Tularik, Inc. | Pentafluorobenzenesulfonamides and analogs |
JP3421350B2 (ja) * | 1996-07-19 | 2003-06-30 | テュラリク インコーポレイテッド | ペンタフルオロベンゼンスルホンアミドおよび類縁体 |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US6087368A (en) * | 1998-06-08 | 2000-07-11 | Bristol-Myers Squibb Company | Quinazolinone inhibitors of cGMP phosphodiesterase |
AU1818400A (en) | 1998-11-12 | 2000-05-29 | Eli Lilly And Company | Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles |
CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
KR100423899B1 (ko) * | 2000-05-10 | 2004-03-24 | 주식회사 엘지생명과학 | 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸 |
US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
JP4535680B2 (ja) | 2001-04-16 | 2010-09-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規1h−インダゾール化合物 |
US7199147B2 (en) | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
US7064215B2 (en) * | 2001-07-03 | 2006-06-20 | Chiron Corporation | Indazole benzimidazole compounds |
WO2003024969A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
FR2836914B1 (fr) * | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
-
2002
- 2002-03-11 FR FR0202996A patent/FR2836914B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-06 GT GT200300031A patent/GT200300031A/es unknown
- 2003-02-13 PA PA20038566701A patent/PA8566701A1/es unknown
- 2003-02-24 TW TW092103799A patent/TW200303863A/zh unknown
- 2003-03-03 SV SV2003001493A patent/SV2003001493A/es not_active Application Discontinuation
- 2003-03-07 MX MXPA04008446A patent/MXPA04008446A/es active IP Right Grant
- 2003-03-07 JP JP2003576408A patent/JP4643910B2/ja not_active Expired - Fee Related
- 2003-03-07 OA OA1200400236A patent/OA12784A/fr unknown
- 2003-03-07 AU AU2003242808A patent/AU2003242808B2/en not_active Ceased
- 2003-03-07 EP EP03744395A patent/EP1487803A1/fr not_active Withdrawn
- 2003-03-07 KR KR10-2004-7014298A patent/KR20040091128A/ko not_active Application Discontinuation
- 2003-03-07 RU RU2004130280/04A patent/RU2004130280A/ru not_active Application Discontinuation
- 2003-03-07 BR BR0308339-0A patent/BR0308339A/pt not_active IP Right Cessation
- 2003-03-07 CA CA002478540A patent/CA2478540A1/fr not_active Abandoned
- 2003-03-07 PE PE2003000232A patent/PE20040071A1/es not_active Application Discontinuation
- 2003-03-07 CN CNB038058731A patent/CN100369899C/zh not_active Expired - Fee Related
- 2003-03-07 WO PCT/FR2003/000751 patent/WO2003078402A1/fr active Application Filing
- 2003-03-07 IL IL16380503A patent/IL163805A0/xx unknown
- 2003-03-07 PL PL03372389A patent/PL372389A1/xx not_active Application Discontinuation
- 2003-03-10 HN HN2003000094A patent/HN2003000094A/es unknown
- 2003-03-10 AR ARP030100807A patent/AR038914A1/es unknown
- 2003-03-11 US US10/385,870 patent/US6858638B2/en not_active Expired - Lifetime
- 2003-03-11 UY UY27712A patent/UY27712A1/es unknown
-
2004
- 2004-08-12 MA MA27825A patent/MA27176A1/fr unknown
- 2004-08-24 ZA ZA200406730A patent/ZA200406730B/en unknown
- 2004-08-30 IL IL163805A patent/IL163805A/en not_active IP Right Cessation
- 2004-09-10 HR HR20040825A patent/HRP20040825A2/hr not_active Application Discontinuation
- 2004-09-10 EC EC2004005286A patent/ECSP045286A/es unknown
- 2004-09-10 TN TNP2004000175A patent/TNSN04175A1/fr unknown
- 2004-10-07 NO NO20044261A patent/NO20044261L/no unknown
- 2004-10-13 US US10/963,880 patent/US7473701B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20040071A1 (es) | Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
PE20070108A1 (es) | Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n-[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
BR0114045A (pt) | Poliarilcarboxamidas úteis como agentes redutores de lipìdeos | |
PE20070138A1 (es) | Compuestos heterociclicos como inhibidores de aspartil proteasas | |
CY1110904T1 (el) | Φαρμακευτικως ενεργα παραγωγα βενζοσουλφοναμιδιου ως αναστολεις πρωτεϊνικων κινασων jun | |
EA200301306A1 (ru) | Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение | |
DE60212867D1 (de) | Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel | |
PE20021089A1 (es) | Compuestos de triazol como inhibidores de las citoquinas | |
NO20034291L (no) | 2-aminopropanolderivater | |
PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
PE20060381A1 (es) | Analogos de dipeptidos inhibidores de la hepatitis c | |
PE20030062A1 (es) | Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas | |
AR023152A1 (es) | Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
AR037901A1 (es) | Beta-amino-alfa-cianoacrilatos | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
PA8495101A1 (es) | Derivados de 13-metileritromicina | |
DK1399436T3 (da) | Oxytocinagonister | |
CR10974A (es) | Inhibidores de carboxipeptidasa b plasmatica (divisional) | |
EA200600694A1 (ru) | Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение | |
MA28286A1 (fr) | Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant | |
SE0104250D0 (sv) | Heterocyclic compounds | |
PE20021018A1 (es) | DERIVADOS DE ß - CARBOLINA | |
AR002741A1 (es) | Benciloxicarbonilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamentoque las contiene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |